Vasoactive peptide urotensin II in plasma is associated with cerebral vasospasm after aneurysmal subarachnoid hemorrhage and constitutes a potential therapeutic target

Thomas Clavier (1) , Laurence Desrues (2, 1) , G Gastaldi , Martine Dubois (2, 1, 3) , Vincent Compère (2, 1, 4) , Hélène Castel (2, 1, 3)

1 DC2N - Différenciation et communication neuronale et neuroendocrine
2 DC2N - Différenciation et communication neuronale et neuroendocrine
3 Plateforme Cancer et Cognition
4 Service d'Anesthésie et Soins intensifs [CHU Rouen]

Domaines: Sciences du Vivant [q-bio]; Neurosciences [q-bio.NC]

Thomas Clavier, Laurence Desrues, G Gastaldi, Martine Dubois, Vincent Compère, et al.. Vasoactive peptide urotensin II in plasma is associated with cerebral vasospasm after aneurysmal subarachnoid hemorrhage and constitutes a potential therapeutic target. Euroanaesthesia 2017 Congress, Jun 2017, Geneva, Switzerland. ⟨hal-02344976⟩